118 related articles for article (PubMed ID: 37603464)
1. Cancer Cell Membrane-Enveloped Dexamethasone Normalizes the Tumor Microenvironment and Enhances Gynecologic Cancer Chemotherapy.
Li M; Wang Y; Zhang L; Liu Q; Jiang F; Hou W; Wang Y; Fang H; Zhang Y
ACS Nano; 2023 Sep; 17(17):16703-16714. PubMed ID: 37603464
[TBL] [Abstract][Full Text] [Related]
2. TGF-β inhibition combined with cytotoxic nanomedicine normalizes triple negative breast cancer microenvironment towards anti-tumor immunity.
Panagi M; Voutouri C; Mpekris F; Papageorgis P; Martin MR; Martin JD; Demetriou P; Pierides C; Polydorou C; Stylianou A; Louca M; Koumas L; Costeas P; Kataoka K; Cabral H; Stylianopoulos T
Theranostics; 2020; 10(4):1910-1922. PubMed ID: 32042344
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone Increases Cisplatin-Loaded Nanocarrier Delivery and Efficacy in Metastatic Breast Cancer by Normalizing the Tumor Microenvironment.
Martin JD; Panagi M; Wang C; Khan TT; Martin MR; Voutouri C; Toh K; Papageorgis P; Mpekris F; Polydorou C; Ishii G; Takahashi S; Gotohda N; Suzuki T; Wilhelm ME; Melo VA; Quader S; Norimatsu J; Lanning RM; Kojima M; Stuber MD; Stylianopoulos T; Kataoka K; Cabral H
ACS Nano; 2019 Jun; 13(6):6396-6408. PubMed ID: 31187975
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone simulates the anticancer effect of nano-formulated paclitaxel in breast cancer cells.
Diab T; AlKafaas SS; Shalaby TI; Hessien M
Bioorg Chem; 2020 Jun; 99():103792. PubMed ID: 32240873
[TBL] [Abstract][Full Text] [Related]
5. Tumor microenvironment targeting system for glioma treatment via fusion cell membrane coating nanotechnology.
Ma J; Dai L; Yu J; Cao H; Bao Y; Hu J; Zhou L; Yang J; Sofia A; Chen H; Wu F; Xie Z; Qian W; Zhan R
Biomaterials; 2023 Apr; 295():122026. PubMed ID: 36731366
[TBL] [Abstract][Full Text] [Related]
6. Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparticle-mediated synergistic metabolic therapy and chemotherapy for non-small cell lung cancer.
Zhang W; Gong C; Chen Z; Li M; Li Y; Gao J
J Nanobiotechnology; 2021 Oct; 19(1):339. PubMed ID: 34689761
[TBL] [Abstract][Full Text] [Related]
7. Engineered nanomedicine for myeloma and bone microenvironment targeting.
Swami A; Reagan MR; Basto P; Mishima Y; Kamaly N; Glavey S; Zhang S; Moschetta M; Seevaratnam D; Zhang Y; Liu J; Memarzadeh M; Wu J; Manier S; Shi J; Bertrand N; Lu ZN; Nagano K; Baron R; Sacco A; Roccaro AM; Farokhzad OC; Ghobrial IM
Proc Natl Acad Sci U S A; 2014 Jul; 111(28):10287-92. PubMed ID: 24982170
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone enhances cell resistance to chemotherapy by increasing adhesion to extracellular matrix in human ovarian cancer cells.
Chen YX; Wang Y; Fu CC; Diao F; Song LN; Li ZB; Yang R; Lu J
Endocr Relat Cancer; 2010 Mar; 17(1):39-50. PubMed ID: 19776289
[TBL] [Abstract][Full Text] [Related]
9. Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following paclitaxel and carboplatin in patients with gynecologic cancers: A randomized, multicenter, phase-II trial.
Matsuura M; Satohisa S; Teramoto M; Tanaka R; Iwasaki M; Nishikawa A; Mizunuma M; Tanaka S; Hayakawa O; Saito T
J Obstet Gynaecol Res; 2015 Oct; 41(10):1607-13. PubMed ID: 26199182
[TBL] [Abstract][Full Text] [Related]
10. Local drug delivery using poly(lactic-co-glycolic acid) nanoparticles in thermosensitive gels for inner ear disease treatment.
Kim DH; Nguyen TN; Han YM; Tran P; Rho J; Lee JY; Son HY; Park JS
Drug Deliv; 2021 Dec; 28(1):2268-2277. PubMed ID: 34668836
[TBL] [Abstract][Full Text] [Related]
11. Novel Nano-Therapeutic Approach Actively Targets Human Ovarian Cancer Stem Cells after Xenograft into Nude Mice.
Abou-ElNaga A; Mutawa G; El-Sherbiny IM; Abd-ElGhaffar H; Allam AA; Ajarem J; Mousa SA
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417924
[TBL] [Abstract][Full Text] [Related]
12. The pro-adhesive and pro-survival effects of glucocorticoid in human ovarian cancer cells.
Yin L; Fang F; Song X; Wang Y; Huang G; Su J; Hui N; Lu J
J Mol Endocrinol; 2016 Jul; 57(1):61-72. PubMed ID: 27151574
[TBL] [Abstract][Full Text] [Related]
13. Microenvironment-driven sequential ferroptosis, photodynamic therapy, and chemotherapy for targeted breast cancer therapy by a cancer-cell-membrane-coated nanoscale metal-organic framework.
Pan WL; Tan Y; Meng W; Huang NH; Zhao YB; Yu ZQ; Huang Z; Zhang WH; Sun B; Chen JX
Biomaterials; 2022 Apr; 283():121449. PubMed ID: 35247637
[TBL] [Abstract][Full Text] [Related]
14. Dual-Targeting Nanoparticles for In Vivo Delivery of Suicide Genes to Chemotherapy-Resistant Ovarian Cancer Cells.
Cocco E; Deng Y; Shapiro EM; Bortolomai I; Lopez S; Lin K; Bellone S; Cui J; Menderes G; Black JD; Schwab CL; Bonazzoli E; Yang F; Predolini F; Zammataro L; Altwerger G; de Haydu C; Clark M; Alvarenga J; Ratner E; Azodi M; Silasi DA; Schwartz PE; Litkouhi B; Saltzman WM; Santin AD
Mol Cancer Ther; 2017 Feb; 16(2):323-333. PubMed ID: 27956521
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone-loaded block copolymer nanoparticles induce leukemia cell death and enhance therapeutic efficacy: a novel application in pediatric nanomedicine.
Krishnan V; Xu X; Barwe SP; Yang X; Czymmek K; Waldman SA; Mason RW; Jia X; Rajasekaran AK
Mol Pharm; 2013 Jun; 10(6):2199-210. PubMed ID: 23194373
[TBL] [Abstract][Full Text] [Related]
16. Alleviation of Surgery-Induced Osteitis in Sinonasal Cavity by Dexamethasone-Loaded Poly(lactic-
Hong SN; Kim M; Park JA; Kang M; Cha H; Park S; Kim JK; Pac J; Seo Y; Kim S; Kim M; Kim DW; Lee Y
Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335922
[TBL] [Abstract][Full Text] [Related]
17. The dosage effects of dexamethasone on osteogenic activity andbiocompatibility of poly(lactic-co-glycolic acid)/hydroxyapatite nanofibers.
Li C; Wang B; Liu X; Pan Z; Liu C; Ma H; Liu X; Liu L; Jiang C
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1823-1832. PubMed ID: 31066304
[TBL] [Abstract][Full Text] [Related]
18. Specific targeting of A54 homing peptide-functionalized dextran-g-poly(lactic-co-glycolic acid) micelles to tumor cells.
Situ JQ; Ye YQ; Zhu XL; Yu RS; You J; Yuan H; Hu FQ; Du YZ
Int J Nanomedicine; 2015; 10():665-75. PubMed ID: 25653517
[TBL] [Abstract][Full Text] [Related]
19. Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancer.
Matthaiou EI; Barar J; Sandaltzopoulos R; Li C; Coukos G; Omidi Y
Int J Nanomedicine; 2014; 9():1855-70. PubMed ID: 24790428
[TBL] [Abstract][Full Text] [Related]
20. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
